12/4
01:06 pm
bayry
Study that said glyphosate herbicide is safe retracted 25 years after publication [Yahoo! Finance Canada]
Low
Report
Study that said glyphosate herbicide is safe retracted 25 years after publication [Yahoo! Finance Canada]
12/4
02:30 am
bayry
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
Low
Report
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
12/4
12:08 am
bayry
Taboo no more: Leaders gather to discuss women's health [Globe and Mail, The (Toronto, Canada)]
Low
Report
Taboo no more: Leaders gather to discuss women's health [Globe and Mail, The (Toronto, Canada)]
12/3
05:54 pm
bayry
Trump administration backs Bayer as Roundup fight moves toward Supreme Court [FOX Business Network]
Low
Report
Trump administration backs Bayer as Roundup fight moves toward Supreme Court [FOX Business Network]
12/3
01:00 pm
bayry
RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
Low
Report
RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
12/3
09:02 am
bayry
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.
Low
Report
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.
12/2
02:10 pm
bayry
Bayer Shares Jump As Trump Boosts Limits On Weedkiller Lawsuits [Barron's]
Neutral
Report
Bayer Shares Jump As Trump Boosts Limits On Weedkiller Lawsuits [Barron's]
12/2
08:05 am
bayry
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
Low
Report
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
12/2
06:00 am
bayry
Bayer Crop Science Canada Launches EverGol Rise for Enhanced User Experience in Pulse Disease Control
High
Report
Bayer Crop Science Canada Launches EverGol Rise for Enhanced User Experience in Pulse Disease Control
12/1
11:30 am
bayry
Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
Low
Report
Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
11/28
12:03 am
bayry
How a national menopause strategy could improve health equity – and Canada's economy [Globe and Mail, The (Toronto, Canada)]
Low
Report
How a national menopause strategy could improve health equity – and Canada's economy [Globe and Mail, The (Toronto, Canada)]
11/23
11:28 am
bayry
Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
High
Report
Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
11/20
08:00 am
bayry
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Low
Report
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
11/18
08:01 am
bayry
[Latest] Global Yellow Phosphorus & Derivatives Market Size/Share Worth USD 9.02 Billion by 2034 at a 5.34% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Financ
Low
Report
[Latest] Global Yellow Phosphorus & Derivatives Market Size/Share Worth USD 9.02 Billion by 2034 at a 5.34% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Financ
11/13
11:41 am
bayry
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
11/12
02:37 pm
bayry
Bayer AG (BAYRY) Q3 2025 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges [Yahoo! Finance]
Neutral
Report
Bayer AG (BAYRY) Q3 2025 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges [Yahoo! Finance]
11/12
06:02 am
bayry
Yellow Phosphorus & Derivatives Industry Research and Global Forecast Report 2025-2030: $6.91 Bn Market Opportunities in Rising Demand for Flame Retardants, Plastic Additives, and Food & Beverage [Yahoo! Finance]
Medium
Report
Yellow Phosphorus & Derivatives Industry Research and Global Forecast Report 2025-2030: $6.91 Bn Market Opportunities in Rising Demand for Flame Retardants, Plastic Additives, and Food & Beverage [Yahoo! Finance]
11/10
07:01 am
bayry
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
Low
Report
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
11/9
08:12 pm
bayry
Farmdar Secures Strategic Investment from Asian Development Bank to Scale AI for Agriculture Across Emerging Asia. [Yahoo! Finance]
Low
Report
Farmdar Secures Strategic Investment from Asian Development Bank to Scale AI for Agriculture Across Emerging Asia. [Yahoo! Finance]
11/7
10:22 pm
bayry
Tennessee Lady Vols basketball vs. ETSU Buccaneers, our best photos [USA TODAY]
Low
Report
Tennessee Lady Vols basketball vs. ETSU Buccaneers, our best photos [USA TODAY]
11/6
01:00 pm
bayry
Neotribe Ventures Marks IPO of Portfolio Company BillionToOne, Celebrating a Partnership Built on Bold Ideas and Long-Term Vision
Low
Report
Neotribe Ventures Marks IPO of Portfolio Company BillionToOne, Celebrating a Partnership Built on Bold Ideas and Long-Term Vision
11/6
11:44 am
bayry
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
Low
Report
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
11/6
09:00 am
bayry
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
Low
Report
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
11/5
07:31 am
bayry
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/24
01:25 pm
bayry
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
Low
Report
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause